non-targeting control gRNA (BRDN0001145885) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing non-targeting control gRNA (BRDN0001145885)

Articles
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy. Shapiro DD, Zacharias NM, Tripathi DN, Karki M, Bertocchio JP, Soeung M, He R, Westerman ME, Gao J, Rao P, Lam TNA, Jonasch E, Perelli L, Cheng EH, Carugo A, Heffernan TP, Walker CL, Genovese G, Tannir NM, Karam JA, Msaouel P. Clin Transl Med. 2023 May;13(5):e1267. doi: 10.1002/ctm2.1267. PubMed

If you have published an article using this material, please email us at to have your article added to this page.